Article
Radiology, Nuclear Medicine & Medical Imaging
Ken-ichi Kaneko, Satsuki Irie, Aya Mawatari, Ami Igesaka, Di Hu, Takayoshi Nakaoka, Emi Hayashinaka, Yasuhiro Wada, Hisashi Doi, Yasuyoshi Watanabe, Yilong Cui
Summary: This study quantitatively analyzed the spatiotemporal changes in neuroinflammation after status epilepticus in rats, using TSPO PET imaging. The results provide valuable evidence for developing new anti-inflammatory therapies for epilepsy, with activated microglia identified as a crucial therapeutic target in the early phase after status epilepticus.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2022)
Article
Neurosciences
Savannah M. Rocha, Kelly S. Kirkley, Debotri Chatterjee, Tawfik A. Aboellail, Richard J. Smeyne, Ronald B. Tjalkens
Summary: Parkinson's disease is the most common neurodegenerative movement disorder worldwide, with a higher prevalence in men. The cause of the disease is largely unknown, but environmental exposures and neuroinflammation are linked to the misfolding of proteins and disease progression. Activated microglia play a role in promoting neuroinflammation in Parkinson's disease, but the interaction between environmental agents and specific innate immune signaling pathways in microglia is not well understood.
Article
Radiology, Nuclear Medicine & Medical Imaging
Francisco R. Lopez-Picon, Thomas Keller, Diana Bocancea, Jatta S. Helin, Anna Krzyczmonik, Semi Helin, Annelaure Damont, Frederic Dolle, Juha O. Rinne, Merja Haaparanta-Solin, Olof Solin
Summary: In this study, the newly developed TSPO tracer [F-18]F-DPA showed higher brain uptake, higher TG-to-WT SUVRCB ratios, and faster clearance compared to [F-18]DPA-714 and [C-11]PBR28. These findings suggest that [F-18]F-DPA could be a useful tool for detecting low levels of inflammation and allowing for shorter dynamic PET scans.
MOLECULAR IMAGING AND BIOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Peizhen Ye, Lei Bi, Min Yang, Yifan Qiu, Guolong Huang, Yongshan Liu, Yuyi Hou, Zhijun Li, Henry Hoi Yee Tong, Mengchao Cui, Hongjun Jin
Summary: In this study, the expression of TSPO was measured using [18F]DPA-714 positron emission tomography-magnetic resonance imaging (PET-MRI) to investigate the effects of microglial activation associated with motor behavioral impairments in a rodent model of Parkinson's disease (PD). The results showed elevated TSPO binding in the striatum during the first three weeks post-treatment, indicating potential neuroinflammation in the early stage of PD. [18F]DPA-714 could be a potential PET tracer for imaging microglia-mediated neuroinflammation in early PD.
ACS CHEMICAL NEUROSCIENCE
(2023)
Article
Biochemistry & Molecular Biology
Peizhen Ye, Lei Bi, Min Yang, Yifan Qiu, Guolong Huang, Yongshan Liu, Yuyi Hou, Zhijun Li, Henry Hoi Yee Tong, Mengchao Cui, Hongjun Jin
Summary: In this study, TSPO expression was investigated using [18F]DPA-714 positron emission tomography-magnetic resonance imaging (PET-MRI) to study microglial activation and motor behavioral impairments in a rodent model of Parkinson's disease (PD) treated with 6-hydroxydopamine (6-OHDA). The results showed an increase in striatal [18F]DPA-714 binding ratio during the first three weeks post-treatment, with the peak TSPO binding in the first week. There was a significant correlation between [18F]DPA-714 SUVRR/L and rotation numbers, indicating the potential of [18F]DPA-714 as a PET tracer for imaging microglia-mediated neuroinflammation in early PD.
ACS CHEMICAL NEUROSCIENCE
(2023)
Review
Biochemistry & Molecular Biology
Madiha Rasheed, Junhan Liang, Chaolei Wang, Yulin Deng, Zixuan Chen
Summary: Neuroinflammation plays a significant role in the initiation and progression of Parkinson's disease, activating the neuronal immune system and triggering a vicious cycle of inflammation-induced dopaminergic neuron damage. Epigenetic mechanisms are at the forefront of regulating neuroinflammatory factors, offering potential for breaking this cycle. These mechanisms do not work independently but cooperatively, impacting various neuroinflammatory pathways and potentially influencing PD development.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Cell Biology
Hai-Yue Tu, Bao-Shi Yuan, Xiao-Ou Hou, Xiao-Jun Zhang, Chong-Shuang Pei, Ya-Ting Ma, Ya-Ping Yang, Yi Fan, Zheng-Hong Qin, Chun-Feng Liu, Li-Fang Hu
Summary: The extracellular transfer of alpha-Synuclein (alpha-Syn) contributes to Parkinson's disease pathogenesis by activating microglia and neuroinflammation. This study found that extracellular alpha-Syn inhibits microglia autophagy through Toll-like receptor 4 (Tlr4)-mediated p38 and Akt-mTOR signaling pathways, leading to neuroinflammation and PD development.
Review
Immunology
Yunna Li, Yun Xia, Sijia Yin, Fang Wan, Junjie Hu, Liang Kou, Yadi Sun, Jiawei Wu, Qiulu Zhou, Jinsha Huang, Nian Xiong, Tao Wang
Summary: Recent studies have shown that the excessive activation of microglia and release of pro-inflammatory cytokines play crucial roles in the pathogenesis and progression of Parkinson's disease (PD). The elevated level of NLRP3 inflammasome in activated microglia in the substantia nigra of PD patients exacerbates the pathology and accelerates disease progression. Current therapeutic drugs for PD primarily focus on relieving clinical symptoms, as there are no established strategies to stop or reverse the disease.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
M. A. Peyronneau, B. Kuhnast, D-L Nguyen, B. Jego, G. Sayet, F. Caille, S. Lavisse, P. Gervais, B. Stankoff, M. Sarazin, P. Remy, V Bouilleret, C. Leroy, M. Bottlaender
Summary: This study aimed to assess the impact of concomitant medication, age, sex, body mass index, and TSPO binding affinity on the metabolism and plasma pharmacokinetics of [F-18]DPA-714 and their influence on the plasma input function. The results showed significant correlations between concomitant medication, age, sex, body mass index, and [F-18]DPA-714 metabolism and concentration.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
(2023)
Review
Biochemistry & Molecular Biology
Gaylia Jean Harry
Summary: Changes in microglia are commonly associated with neurodegeneration, but it is not clear if they initiate the process. Communication between microglia and neurons helps maintain the cells in a surveillance state, suggesting a partnership role rather than an initiating one in neurodegeneration.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Neurosciences
Jiamei Guo, Tian Qiu, Lixia Wang, Lei Shi, Ming Ai, Zhu Xia, Zhiping Peng, Anhai Zheng, Xiao Li, Li Kuang
Summary: In this study, the role of glial cells in stress-induced depression was investigated. The findings suggest that changes in glial cells may contribute to the development and symptoms of depression.
FRONTIERS IN CELLULAR NEUROSCIENCE
(2022)
Review
Biochemistry & Molecular Biology
Johan Wallin, Per Svenningsson
Summary: Parkinson's disease is a neurodegenerative disorder with a significant immune component, both centrally and peripherally, indicating immunomodulation as a potential treatment strategy. The leukotriene pathway, specifically montelukast as a leukotriene receptor antagonist, shows promise as an anti-inflammatory treatment for PD.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Review
Clinical Neurology
Ashley S. Harms, Sara A. Ferreira, Marina Romero-Ramos
Summary: Parkinson's disease involves both neuronal events and a significant immune component, with changes in the immune system occurring in both the central nervous system and the periphery. Alpha-synuclein plays a crucial role in activating the innate and adaptive immune system, contributing to neuronal degeneration and symptomatology in patients.
ACTA NEUROPATHOLOGICA
(2021)
Review
Cell Biology
Qian-Kun Lv, Kang-Xin Tao, Xiao-Bo Wang, Xiao-Yu Yao, Meng-Zhu Pang, Jun-Yi Liu, Fen Wang, Chun-Feng Liu
Summary: Parkinson's disease is a common neurodegenerative disease characterized by the accumulation of alpha-synuclein in microglia, leading to neuroinflammation. The autophagy and phagocytosis functions of microglia are related to the clearance of alpha-synuclein and the inhibition of neuroinflammation. This review discusses the interaction between microglia and alpha-synuclein in Parkinson's disease pathogenesis, and the possible mechanisms of microglial autophagy and phagocytosis in the clearance of alpha-synuclein and inhibition of neuroinflammation.
INFLAMMATION RESEARCH
(2023)
Review
Biochemistry & Molecular Biology
Ritu Soni, Prashant Delvadia, Amit Joharapurkar, Jigna Shah
Summary: Parkinson's disease (PD) is a common progressive disorder characterized by deposition of inclusion bodies on dopaminergic neurons in the brain. The major component of these inclusion bodies is α-synuclein aggregates, which gradually propagate PD pathology. Underexplored molecular targets could potentially aid in the development of novel therapeutics for PD.
ACS CHEMICAL NEUROSCIENCE
(2023)
Review
Clinical Neurology
Antonio Martin-Bastida, Manuel Delgado-Alvarado, Irene Navalpotro-Gomez, Maria Cruz Rodriguez-Oroz
Summary: Dementia, mild cognitive impairment, and neuropsychiatric symptoms are common non-motor symptoms of Parkinson's disease. Neuroimaging studies play a critical role in early diagnosis, monitoring, and understanding the pathophysiology of cognitive and neuropsychiatric symptoms associated with PD. This literature review provides an update on the latest neuroimaging findings for assessing cognitive dysfunction and impulse control disorders in PD.
FRONTIERS IN NEUROLOGY
(2021)
Article
Clinical Neurology
Leyre Merino-Galan, Haritz Jimenez-Urbieta, Marta Zamarbide, Tatiana Rodriguez-Chinchilla, Arantzazu Belloso-Iguerategui, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Ana Aiastui, Evelyne Doudnikoff, Erwan Bezard, Alberto Ouro, Shira Knafo, Belen Gago, Ana Quiroga-Varela, Maria Cruz Rodriguez-Oroz
Summary: In Parkinson's disease, synaptic impairment may occur before neuronal degeneration. By studying a rat model, we found that synaptic energetic failure and accumulation of dysfunctional organelles are the earliest events that happen at dopaminergic terminals, preceding structural changes and cell death. We also identified key proteins involved in these earliest functional abnormalities, which could be targeted for therapeutic interventions to delay or prevent the development of Parkinson's disease.
Article
Clinical Neurology
Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, Agustin Pappolla, Paula Tagliani, Samuel Lopez-Maza, Simon Cardenas-Robledo, Juliana Esperalba, Candela Fernandez-Naval, Monica Martinez-Gallo, Mireia Castillo, Merce Bonastre, Mireia Resina-Salles, Jordina Bertran, Marta Rodriguez-Barranco, Pere Carbonell-Mirabent, Marina Gonzalez, Miguel Merchan, Ana Quiroga-Varela, Albert Miguela, Imma Gomez, Gary Alvarez, Rene Robles, Dunia Perez Del Campo, Xavier Queralt, Maria Jose Soler, Irene Agraz, Fernando Martinez-Valle, Breogan Rodriguez-Acevedo, Luciana Midaglia, Angela Vidal-Jordana, Alvaro Cobo-Calvo, Carmen Tur, Ingrid Galan, Joaquin Castillo, Jordi Rio, Carmen Espejo, Manuel Comabella, Carlos Nos, Jaume Sastre-Garriga, Lluis Ramio-Torrenta, Mar Tintore, Xavier Montalban
Summary: Anti-CD20 and S1PRM modify the immunological responses to SARS-CoV-2 vaccines, with humoral response decreasing under these treatments and with longer duration, while patients on anti-CD20 can still present cellular responses even in the absence of antibodies.
MULTIPLE SCLEROSIS JOURNAL
(2022)
Article
Biochemistry & Molecular Biology
Melina Decourt, Eric Balado, Haritz Jimenez-Urbieta, Maureen Francheteau, Pierre-Olivier Fernagut, Marianne Benoit-Marand
Summary: Treatment with dopamine agonists in Parkinson's disease is associated with impulsive and compulsive behaviors. This vulnerability is influenced by individual traits, medication types, and neurodegenerative processes. This study investigates the effect of the dopamine D3/D2 agonist pramipexole and selective nigrostriatal degeneration on repetitive and compulsive-like behaviors in rats.
Article
Clinical Neurology
Maria Munoz-San Martin, Imma Gomez, Ana Quiroga-Varela, Marina Gonzalez-del Rio, Rene Robles Cedeno, Gary Alvarez, Maria Buxo, Albert Miguela, Luisa M. Villar, Jessica Castillo-Villalba, Bonaventura Casanova, Ester Quintana, Lluis Ramio-Torrenta
Summary: By analyzing miRNAs in CSF and serum samples, specific dysregulated miRNAs were found in PPMS patients, which could be potential biomarkers for further study of their role in multiple sclerosis.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
(2023)
Article
Clinical Neurology
Enric Monreal, Jose Ignacio Fernandez-Velasco, Maria Isabel Garcia-Sanchez, Susana Sainz de la Maza, Sara Llufriu, Roberto Alvarez-Lafuente, Bonaventura Casanova, Manuel Comabella, Lluis Ramio-Torrenta, Jose Enrique Martinez-Rodriguez, Luis Brieva, Albert Saiz, Sara Eichau, Jose Maria Cabrera-Maqueda, Noelia Villarrubia, Mercedes Espino, Francisco Perez-Miralles, Xavier Montalban, Mar Tintore, Ana Quiroga-Varela, Maria Inmaculada Dominguez-Mozo, Fernando Rodriguez-Jorge, Juan Luis Chico-Garcia, Daniel Lourido, Jose Carlos Alvarez-Cermeno, Jaime Masjuan, Lucienne Costa-Frossard, Luisa Maria Villar
Summary: This multicenter cohort study found that high serum neurofilament light chain (sNfL) values obtained within the first year of disease were associated with long-term disability worsening in patients with multiple sclerosis (MS), suggesting that sNfL level measurement may help identify optimal candidates for highly effective disease-modifying treatments.
Article
Clinical Neurology
Marc Puig-Casadevall, Gary Alvarez-Bravo, Ana Quiroga Varela, Rene Robles-Cedeno, Laura Sanchez Cirera, Albert Miguela, Gemma Laguillo, Xavier Montalban, Stephen L. Hauser, Lluis Ramio-Torrenta
Summary: This case report describes the occurrence of progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosis treated with ocrelizumab without previous use of natalizumab. Although this condition is usually associated with natalizumab treatment, its occurrence with other immunosuppressive therapies has also been reported.
EUROPEAN JOURNAL OF NEUROLOGY
(2023)
Meeting Abstract
Clinical Neurology
T. Esteban-Penalba, P. Paz-Alonso, I. Navalpotro-Gomez, M. Rodriguez-Oroz
MOVEMENT DISORDERS
(2021)
Meeting Abstract
Clinical Neurology
I. Aviles-Olmos, A. Martin-Bastida, A. Gorospe-Osinalde, J. Carte-Garcia, P. Manrique, A. Arcadi, O. Parras, M. Fernandez-Martinez, L. Armengou-Garcia, L. Gonzalez-Quarante, J. Guridi, M. C. Rodriguez-Oroz
MOVEMENT DISORDERS
(2021)
Meeting Abstract
Clinical Neurology
S. Basaia, F. Agosta, I. Diez Palacio, E. Bueicheku, F. d'Oleire Uquillas, M. Delgado-Alvarado, C. Caballero-Gaudes, M. Rodriguez-Oroz, T. Stojkovic, V. Kostic, M. Filippi, J. Sepulcre
MOVEMENT DISORDERS
(2021)
Review
Psychology, Multidisciplinary
Angela Milan-Tomas, Marta Fernandez-Matarrubia, Maria Cruz Rodriguez-Oroz
Summary: Lewy body dementias (LBDs) comprise dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), sharing neuropathological features. Updated diagnostic criteria now include biomarker information, with the major clinical distinction being the time interval of dementia onset relative to parkinsonism.
BEHAVIORAL SCIENCES
(2021)
Article
Clinical Neurology
Elena Cacho-Asenjo, Cristina Honorato-Cia, Jorge M. Nunez-Cordoba, Miguel Fernandez-Martinez, Lain H. Gonzalez-Quarante, Iciar Aviles-Olmos, Maria Aranzazu Gorospe, Alfredo Panadero, Maria Cruz Rodriguez-Oroz, Jorge Guridi, Antonio Martinez-Simon
Summary: Headache was associated with skull density ratio and thickness, while nausea was related to sex. Women had higher odds of experiencing nausea compared to men. Dexmedetomidine did not reduce headache or nausea, but increased the number and duration of sonications.
MOVEMENT DISORDERS CLINICAL PRACTICE
(2021)